4-Hydroxy-N-ethyl-N-isobutyltryptamine (4-HO-EiBT, Eibucin) is a substituted tryptamine derivative which acts as a 5-HT2A receptor agonist, with an EC50 of 27.7 nM and an efficacy of 97.5% (vs 5-HT).[1]

4-HO-EiBT
Identifiers
  • 3-{2-[(2-methylpropyl)(ethyl)amino]ethyl}-1H-indol-4-ol
PubChem CID
Chemical and physical data
FormulaC16H24N2O
Molar mass260.381 g·mol−1
3D model (JSmol)
  • CCN(CCc1c[nH]c2cccc(O)c12)CC(C)C
  • InChI=1S/C16H24N2O/c1-4-18(11-12(2)3)9-8-13-10-17-14-6-5-7-15(19)16(13)14/h5-7,10,12,17,19H,4,8-9,11H2,1-3H3
  • Key:ASUXKVXXFBPGCG-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ WO 2023/115167, Banister S, Jorgensen W, Jinlong T, "Compounds", published 2023-06-29, assigned to Psylo Pty Ltd.